Tus kws kho mob
QP90-21 Update for New to Market Medical Drugs: Tezepelumab, Faricimab, and Ranibizumab Injection (Susvimo implant)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 10, 2021
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2001 - 2010 ntawm 3685
Tus kws kho mob
Interleukin-1 (IL-1) Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Interleukin-1 (IL-1) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 01, 2024
Tus kws kho mob
QP86-21 Commercial Pharmacy Benefit Exclusion for Mitigare®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 10, 2021
Tus kws kho mob
QP87-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 10, 2021
Tus kws kho mob
P75-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2021
Tus kws kho mob
P76-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 31, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2021
Tus kws kho mob
BCBSMN-Upcoming-policies-effective-013122.pdf
Tus kws kho mob
P61R1-21 Update: Evaluation and Management Reimbursement Changes
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 01, 2021